MARKET

OTLC

OTLC

Oncotelic Therapeutics Inc
OTCMQB
0.035
+0.003
+10.48%
Closed 15:04 03/16 EDT
OPEN
0.033
PREV CLOSE
0.032
HIGH
0.035
LOW
0.030
VOLUME
694.20K
TURNOVER
21.93K
52 WEEK HIGH
0.108
52 WEEK LOW
0.030
MARKET CAP
15.37M
P/E (TTM)
-8.4878
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OTLC last week (0309-0313)?
Weekly Report · 1d ago
Weekly Report: what happened at OTLC last week (0302-0306)?
Weekly Report · 03/09 09:10
Weekly Report: what happened at OTLC last week (0223-0227)?
Weekly Report · 03/02 09:10
Weekly Report: what happened at OTLC last week (0216-0220)?
Weekly Report · 02/23 09:10
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
Barchart · 02/20 07:30
Weekly Report: what happened at OTLC last week (0209-0213)?
Weekly Report · 02/16 09:10
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
Barchart · 02/12 07:30
Weekly Report: what happened at OTLC last week (0202-0206)?
Weekly Report · 02/09 09:11
More
About OTLC
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small-molecule injectable drugs for the treatment of cancer. The Company has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.

Webull offers Oncotelic Therapeutics Inc stock information, including OTCMQB: OTLC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OTLC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OTLC stock methods without spending real money on the virtual paper trading platform.